irasia.com - BioDiem Limited

BioDiem Limited

Board and Management Team

Board of Directors

Mr Hugh M Morgan AC (Chairman, Non-Executive Director)
Ms. Julie Phillips (Executive Director)
Prof. Larisa Rudenko (Non-Executive Director)

Management Team

Ms. Julie Phillips (Chief Executive Officer)
Ms. Cathy Cropp (Projects Manager)
Ms. Melanie Leydin (Company Secretary) [Appointed on 14 November 2012] and (CFO)

Board of Directors

HUGH M MORGAN AC
Chairman, Non-Executive Director
Hugh Morgan is Principal of First Charnock Pty Ltd. Hugh was appointed Chief Executive Officer of Western Mining Corporation (1990-2003) and prior to that served as an Executive Officer (1976-1986) and then Managing Director (from June 1986). Hugh has served as a Director of Alcoa of Australia Limited (1977-1998 and 2002-2003); Director of Alcoa Inc. (1998-2001); Member of the Board of the Reserve Bank of Australia (1981-1984 and 1996-2007); President of the Australian Japan Business Co-Operation Committee (1999-2006); Joint Chair of the Commonwealth Business Council (2003-2005) and now Emeritus Director; President of the Business Council of Australia (2003-2005) and now an Honorary Member; Member of the Anglo American plc Australian Advisory Board (2006- 2014). Hugh is a Member of the Lafarge International Advisory Board; Chairman of the Order of Australia Association Foundation Limited; Trustee Emeritus of The Asia Society New York; Chairman Emeritus of the Asia Society AustralAsia Centre; Member of the Asia Society Australia Advisory Council; President of the National Gallery of Victoria Foundation. Hugh is a graduate in Law and Commerce from the University of Melbourne.
back to top

JULIE PHILLIPS
Executive Director
Ms Julie Phillips was appointed to the position of Chief Executive Officer on July 14, 2009 and was appointed a Director on May 7, 2010. She has a strong background in the biotech and pharmaceutical industry, having worked as the CEO and Director of start-up Australian biotechnology companies operating in the life sciences sector. Her technical background in clinical trials, regulatory affairs and pharmacoeconomic assessment/pricing of therapeutics was gained in multinational pharmaceutical companies with responsibility for market entry of new products in Australia and New Zealand. She was appointed Chairman of AusBiotech Ltd in October 2014, the peak biotechnology industry association in Australia.
back to top

PROFESSOR LARISA RUDENKO
Non-Executive Director
Professor Rudenko is Head of the Virology Department in the Institute of Experimental Medicine, St. Petersburg, Russia. Professor Rudenko worked with Academician Smorodintsev and has been responsible for the development and clinical trials of the live attenuated influenza vaccines in Russia. She is recognised as one of the world's leading experts in live attenuated influenza vaccines and as such has worked closely over the past 20 years with scientists at the Centers for Disease Control and Prevention, Atlanta, USA in developing effective influenza prophylaxis programs for use in children and in the elderly.
She has published in excess of 225 scientific papers and 42 patents. Under her supervision, 11 PhD and 2 DSc theses have been prepared. In 1999 her contribution to medical science was recognised with the award of the title of Honoured Scientist of the Russian Federation. Professor Rudenko is currently leading the WHO and PATH programs, developing a new pandemic LAIV for developing countries.
back to top

Management Team

JULIE PHILLIPS
Chief Executive Officer
Ms Julie Phillips was appointed to the position of Chief Executive Officer on July 14, 2009 and was appointed a Director on May 7, 2010. She has a strong background in the biotech and pharmaceutical industry, having worked as the CEO and Director of start-up Australian biotechnology companies operating in the life sciences sector. Her technical background in clinical trials, regulatory affairs and pharmacoeconomic assessment/pricing of therapeutics was gained in multinational pharmaceutical companies with responsibility for market entry of new products in Australia and New Zealand. She was appointed Chairman of AusBiotech Ltd in October 2014, the peak biotechnology industry association in Australia.
back to top

CATHY CROPP
Projects Manager
Ms Cropp was appointed Projects Manager in 2010 and is responsible primarily for managing the LAIV vaccine vector and BDM-I antimicrobial projects. Cathy is a microbiologist with over 20 years experience in international quality/compliance, manufacturing and drug, biologicals and vaccine development management in both the international and domestic pharmaceutical and biotech sectors.
Her core skills revolve around Good Laboratory, Manufacturing and Clinical Practice compliance on an international level. She has considerable knowledge in regulatory affairs and clinical development strategies and the development and implementation of manufacturing processes for investigational new therapeutic agents appropriate for clinical use.
back to top

MELANIE LEYDIN
Company Secretary [Appointed on 14 November 2012] and CFO
Ms Leydin was appointed to the position of Company Secretary on 14 November 2012. She is a Chartered Accountant and is a Registered Company Auditor with more than 20 years experience in the accounting profession. In 2000 she established her own chartered accounting practice Leydin Freyer, specialising in audit and public company consulting. Melanie is a director and company secretary for a number of biotech, oil and gas, junior mining and exploration entities listed on the Australian Securities Exchange.
back to top

updated 26th June, 2015

Company's Index

irasia.com

DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited.
TERMS OF USE: Please read the Terms of Use governing the use of our website.

		HUGH M MORGAN AC Chairman, Non-Executive Director Hugh Morgan is Principal of First Charnock Pty Ltd. Hugh was appointed Chief Executive Officer of Western Mining Corporation (1990-2003) and prior to that served as an Executive Officer (1976-1986) and then Managing Director (from June 1986). Hugh has served as a Director of Alcoa of Australia Limited (1977-1998 and 2002-2003); Director of Alcoa Inc. (1998-2001); Member of the Board of the Reserve Bank of Australia (1981-1984 and 1996-2007); President of the Australian Japan Business Co-Operation Committee (1999-2006); Joint Chair of the Commonwealth Business Council (2003-2005) and now Emeritus Director; President of the Business Council of Australia (2003-2005) and now an Honorary Member; Member of the Anglo American plc Australian Advisory Board (2006- 2014). Hugh is a Member of the Lafarge International Advisory Board; Chairman of the Order of Australia Association Foundation Limited; Trustee Emeritus of The Asia Society New York; Chairman Emeritus of the Asia Society AustralAsia Centre; Member of the Asia Society Australia Advisory Council; President of the National Gallery of Victoria Foundation. Hugh is a graduate in Law and Commerce from the University of Melbourne. back to top

		JULIE PHILLIPS Executive Director Ms Julie Phillips was appointed to the position of Chief Executive Officer on July 14, 2009 and was appointed a Director on May 7, 2010. She has a strong background in the biotech and pharmaceutical industry, having worked as the CEO and Director of start-up Australian biotechnology companies operating in the life sciences sector. Her technical background in clinical trials, regulatory affairs and pharmacoeconomic assessment/pricing of therapeutics was gained in multinational pharmaceutical companies with responsibility for market entry of new products in Australia and New Zealand. She was appointed Chairman of AusBiotech Ltd in October 2014, the peak biotechnology industry association in Australia. back to top

		PROFESSOR LARISA RUDENKO Non-Executive Director Professor Rudenko is Head of the Virology Department in the Institute of Experimental Medicine, St. Petersburg, Russia. Professor Rudenko worked with Academician Smorodintsev and has been responsible for the development and clinical trials of the live attenuated influenza vaccines in Russia. She is recognised as one of the world's leading experts in live attenuated influenza vaccines and as such has worked closely over the past 20 years with scientists at the Centers for Disease Control and Prevention, Atlanta, USA in developing effective influenza prophylaxis programs for use in children and in the elderly. She has published in excess of 225 scientific papers and 42 patents. Under her supervision, 11 PhD and 2 DSc theses have been prepared. In 1999 her contribution to medical science was recognised with the award of the title of Honoured Scientist of the Russian Federation. Professor Rudenko is currently leading the WHO and PATH programs, developing a new pandemic LAIV for developing countries. back to top

		JULIE PHILLIPS Chief Executive Officer Ms Julie Phillips was appointed to the position of Chief Executive Officer on July 14, 2009 and was appointed a Director on May 7, 2010. She has a strong background in the biotech and pharmaceutical industry, having worked as the CEO and Director of start-up Australian biotechnology companies operating in the life sciences sector. Her technical background in clinical trials, regulatory affairs and pharmacoeconomic assessment/pricing of therapeutics was gained in multinational pharmaceutical companies with responsibility for market entry of new products in Australia and New Zealand. She was appointed Chairman of AusBiotech Ltd in October 2014, the peak biotechnology industry association in Australia. back to top

CATHY CROPP Projects Manager Ms Cropp was appointed Projects Manager in 2010 and is responsible primarily for managing the LAIV vaccine vector and BDM-I antimicrobial projects. Cathy is a microbiologist with over 20 years experience in international quality/compliance, manufacturing and drug, biologicals and vaccine development management in both the international and domestic pharmaceutical and biotech sectors. Her core skills revolve around Good Laboratory, Manufacturing and Clinical Practice compliance on an international level. She has considerable knowledge in regulatory affairs and clinical development strategies and the development and implementation of manufacturing processes for investigational new therapeutic agents appropriate for clinical use. back to top

MELANIE LEYDIN Company Secretary [Appointed on 14 November 2012] and CFO Ms Leydin was appointed to the position of Company Secretary on 14 November 2012. She is a Chartered Accountant and is a Registered Company Auditor with more than 20 years experience in the accounting profession. In 2000 she established her own chartered accounting practice Leydin Freyer, specialising in audit and public company consulting. Melanie is a director and company secretary for a number of biotech, oil and gas, junior mining and exploration entities listed on the Australian Securities Exchange. back to top